(Q30432926)

14 October 2017

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond (English)

1 reference

14 October 2017

C M Britten

1

1 reference

14 October 2017

S Janetzki

2

1 reference

14 October 2017

S H van der Burg

3

1 reference

14 October 2017

C Huber

4

1 reference

14 October 2017

M Kalos

5

1 reference

14 October 2017

H I Levitsky

6

1 reference

14 October 2017

H T Maecker

7

1 reference

14 October 2017

C J M Melief

8

1 reference

14 October 2017

J O'Donnell-Tormey

9

1 reference

14 October 2017

K Odunsi

10

1 reference

14 October 2017

L J Old

11

1 reference

14 October 2017

G Pawelec

12

1 reference

14 October 2017

B O Roep

13

1 reference

14 October 2017

P Romero

14

1 reference

14 October 2017

A Hoos

15

1 reference

14 October 2017

M M Davis

16

1 reference

14 October 2017

16 November 2010

1 reference

Cancer Immunology, Immunotherapy

14 October 2017

1 reference

14 October 2017

60

1 reference

14 October 2017

1

1 reference

14 October 2017

15-22

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-010-0940-z

14 October 2017

0 references

cites work

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Highly multiparametric analysis by mass cytometry

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

New technologies for autoimmune disease monitoring

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

An integrative paradigm to impart quality to correlative science

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Publishing flow cytometry data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

"MIATA"-minimal information about T cell assays

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

The cancer vaccine roller coaster

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

A prescription for human immunology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

MIFlowCyt: the minimum information about a Flow Cytometry Experiment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Clearing the standards landscape: the semantics of terminology and their impact on toxicogenomics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

One-stop shop for microarray data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Reporting recommendations for tumor marker prognostic studies (REMARK).

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00262-010-0940-Z

Debunking minimum information myths: one hat need not fit all

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029829

Publication of optimized multicolor immunofluorescence panels

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21080166

12 December 2020

inferred from PubMed ID database lookup

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21080166

12 December 2020

inferred from PubMed ID database lookup

Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21080166

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00262-010-0940-Z

1 reference

Dimensions Publication ID

14 October 2017

1037517799

0 references

Fatcat ID

release_rwwx2h3dyrhxzbdkyhjacxshhy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rwwx2h3dyrhxzbdkyhjacxshhy

24 November 2022

mapped directly with Wikidata item

1 reference

14 October 2017

1 reference